The method came from people
who have done this work.

Served as Medical Director at Aetna for 11 years, where she was responsible for developing and applying clinical coverage criteria across medical device categories.

Wrote the criteria that determined coverage for thousands of devices. Her decision logic, the internal reasoning a payer medical director applies when evaluating a device, is the foundation of the Polify analysis framework.

Her contribution to Polify is not advisory. The way Polify reads a payer policy and identifies what it means for a specific device is built on the framework she developed from inside the payer.

Twenty-two years carrying medical devices from FDA clearance to full commercial coverage across every major payer class: commercial, Medicare, Medicaid, and managed care.

Developed the payer lever methodology that identifies which specific actions move which specific payers. Not generic best practices: the actual levers that have worked, payer by payer, device category by device category.

The action plan structure in Polify, prioritized directives, payer-specific levers, deadline sequencing, is built on his methodology. He has done this work at scale, and the product reflects that.

Spent nine years at United Healthcare developing clinical evidence standards for emerging device categories: the criteria that determine whether a device's evidence base is sufficient to support coverage.

Her work focused specifically on the gap between what a device's clinical evidence shows and what a payer's policy requires. That gap, and how to close it, is the core of the Polify evidence analysis.

The evidence gap analysis in Polify reflects her framework: not just identifying what evidence is missing, but mapping the specific citations and study types that each payer's policy requires.

Navigated coverage strategy for Class II and Class III devices at two of the largest medical device companies in the world: Medtronic and Boston Scientific.

His experience spans the full commercialization arc: from pre-market coverage strategy through FDA clearance, launch, payer contracting, and long-term coverage maintenance.

The commercial coverage strategy framework in Polify, how to sequence coverage activities, how to prioritize payers, how to build the evidence package that supports a coverage claim, draws directly from his work at scale.